Sökning: WFRF:(Emadi A.) >
Serum thyroglobulin...
Serum thyroglobulin is associated with orbitopathy in Graves' disease
-
- Khamisi, Selwan (författare)
- Uppsala universitet,Institutionen för medicinska vetenskaper,Uppsala Univ Hosp, Dept Endocrinol & Diabet, S-75185 Uppsala, Sweden
-
- Lundqvist, Martin H. (författare)
- Uppsala universitet,Institutionen för medicinska vetenskaper,Uppsala Univ Hosp, Dept Endocrinol & Diabet, S-75185 Uppsala, Sweden
-
- Emadi, P. (författare)
- Uppsala Univ Hosp, Dept Ophthalmol, Uppsala, Sweden.
-
visa fler...
-
- Almby, Kristina E. (författare)
- Uppsala universitet,Institutionen för medicinska vetenskaper,Uppsala Univ Hosp, Dept Endocrinol & Diabet, S-75185 Uppsala, Sweden.
-
- Ljunggren, O. (författare)
- Uppsala universitet,Institutionen för medicinska vetenskaper,Uppsala Univ Hosp, Dept Endocrinol & Diabet, S-75185 Uppsala, Sweden.
-
- Karlsson, F. A. (författare)
- Uppsala universitet,Institutionen för medicinska vetenskaper,Uppsala Univ Hosp, Dept Endocrinol & Diabet, S-75185 Uppsala, Sweden.
-
visa färre...
-
(creator_code:org_t)
- 2021-01-29
- 2021
- Engelska.
-
Ingår i: Journal of Endocrinological Investigation. - : Springer Nature. - 0391-4097 .- 1720-8386. ; 44:9, s. 1905-1911
- Relaterad länk:
-
https://doi.org/10.1...
-
visa fler...
-
https://uu.diva-port... (primary) (Raw object)
-
https://link.springe...
-
https://urn.kb.se/re...
-
https://doi.org/10.1...
-
visa färre...
Abstract
Ämnesord
Stäng
- Purpose Serum thyroglobulin levels are often elevated in Graves' disease (GD) and in most cases decrease during treatment. Its relation to Graves' orbitopathy (GO) has not been clarified. Previously, a risk of GO has been linked to smoking, TSH receptor stimulation, high TSH-receptor antibodies (TRAb), low thyroid peroxidase and thyroglobulin antibodies (TPOAb, TgAb). Methods We examined Tg levels in 30 consecutive patients with GD were given drug therapy (methimazole + thyroxine) for up to 24 months. GO was identified by clinical signs and symptoms. 17 patients had GO, 11 of whom had it at diagnosis while 6 developed GO during treatment. During the study, 5 subjects were referred to radioiodine treatment, 3 to surgery. The remaining 22 subjects (GO n = 12, non-GO n = 10) completed the drug regimen. Results At diagnosis, Tg levels in GO patients (n = 11) were higher (84, 30-555 mu g/L, median, range) than in non-GO patients (n = 19) (38, 3.5-287 mu g/L), p = 0.042. Adding the 6 subjects who developed eye symptoms during treatment to the GO group (n = 17), yielded p = 0.001 vs. non-GO (n = 13). TRAb tended to be higher, while TPOAb and TgAb tended to be lower in the GO group. For the 22 patients who completed the drug regimen, Tg levels were higher in GO (n = 12) vs. non-GO (n = 10), p = 0.004, whereas TRAb levels did not differ. Conclusion The data may suggest that evaluation of thyroglobulin levels in GD could contribute to identify patients at increased risk of developing GO. Possibly, thyroidal release of Tg in GD reflects a disturbance that also impacts retroorbital tissues.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Reumatologi och inflammation (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Rheumatology and Autoimmunity (hsv//eng)
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Endokrinologi och diabetes (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Endocrinology and Diabetes (hsv//eng)
Nyckelord
- Thyroglobulin
- Graves' disease
- Graves' orbitopathy
- Graves' ophthalmopathy
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas